Latest filing published 17 Jan 2024 for CorMedix Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Elizabeth Masson-Hurlburt: trading record in brief
All filings by Elizabeth Masson-Hurlburt on record concern CorMedix Inc., in the capacity of senior executive. We count 3 filings; the first trade dates from 21 May 2021 and the latest from 12 January 2024.
Sales make up the whole of the open-market record (1 sale, €45k). Outside the open market, there are 2 share grants.
The newest entry dates from 17 January 2024: a share grant of €15k, in CorMedix Inc. Typically, a trade is published a median of 5 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Elizabeth Masson-Hurlburt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0000929638-24-000134:0
- 8,000 shares@ US$6.9242100.0% of flowCommon StockSEC:0001213900-21-029080:0
2 of 2 declarations
